CAS: 1191450-19-7
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | Burixafor hydrobromide REF: 3D-RXB45019CAS: 1191450-19-7 | Min. 95% | A consultar | Lun 19 May 25 |
 | Burixafor hydrobromide REF: TM-T10635CAS: 1191450-19-7 | 98% | A consultar | Mar 27 May 25 |
Burixafor hydrobromide
CAS:1191450-19-7
Please enquire for more information about Burixafor hydrobromide including the price, delivery time and more …
Fórmula:
C27H60Br3N8O6P
Pureza:
Min. 95%
Peso molecular:
863.5 g/mol
Ref: 3D-RXB45019
| 100mg | 969,00 € |
Entrega estimada en Estados Unidos, el Lunes 19 de Mayo de 2025
Burixafor hydrobromide
CAS:1191450-19-7
Burixafor hydrobromide is an oral CXCR4 blocker with anti-angiogenic properties, potentially treating choroid neovascularization.
Fórmula:
C27H52BrN8O3P
Pureza:
98%
Forma y color:
Solid
Peso molecular:
647.644
Ref: TM-T10635
| 25mg | A consultar | ||
| 50mg | A consultar | ||
| 100mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 27 de Mayo de 2025
